Heidelberg, 11 June 2019 – EMBO announces today that 56 life scientists have been elected to its membership, joining a group of more than 1800 of the best researchers in Europe and around the world.
“EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution,” says EMBO Director Maria Leptin.
EMBO Members actively participate in the execution of the organization’s initiatives by serving on Council, committees and editorial boards, by evaluating applications for EMBO funding, by mentoring young scientists and by providing suggestions and feedback on activities.
The 48 new EMBO Members reside in 17 Member States of the European Molecular Biology Conference (EMBC), EMBO’s intergovernmental funding body. The 8 new EMBO Associate Members are researchers currently working in Argentina, Australia, Japan, Singapore and the USA.
Ever since the very first EMBO Council, chaired by Max Perutz, was tasked with selecting and inviting the initial EMBO Members in 1963, new members are nominated and elected by the existing membership. This year, participation in the election process was especially high, with 65% of the eligible existing EMBO Members taking part.
EMBO will formally welcome its new Members and Associate Members at the annual Members’ Meeting in Heidelberg between 29 and 31 October 2019.
An online directory listing all EMBO Members, their affiliations and areas of expertise is available at people.embo.org.
Selected statistics:
– 48 Members and 8 Associate Members were elected
– newly elected Members reside in 22 countries
– 24 new EMBO members (42.9%) are women
New EMBO Members 2019
- Andrea Ablasser, Swiss Federal Institute of Technology (EPFL), Lausanne, CH
- Sonja-Verena Albers, Universitaet Freiburg, DE
- Roberto Bassi, Universita degli Studi, Verona, IT
- Peter Baumann, Institute of Molecular Biology (IMB) and Johannes Gutenberg University, Mainz, DE
- Richard Benton, University of Lausanne, CH
- Judith Berman, Tel Aviv University, IL
- Melanie Blokesch, Swiss Federal Institute of Technology (EPFL), Lausanne, CH
- Wout Boerjan, VIB-UGent Center for Plant Systems Biology, Gent, BE
- Alain Chedotal, Institut de la Vision, Paris, FR
- Peter R. Cook, University of Oxford, UK
- Nynke H. Dekker, Kavli Institute of Nanoscience Delft, Delft University of Technology, NL
- Andrzej Dziembowski, The Polish Academy of Sciences, Warsaw, PL
- Sadaf Farooqi, University of Cambridge, UK
- George A. Garinis, University of Crete and IMBB – FORTH, Heraklion, GR
- Fanni Gergely, Cancer Research UK Cambridge Institute, University of Cambridge, UK
- Jose Luis Gomez-Skarmeta, Universidad Pablo de Olavide, Sevilla, ES
- Thomas Gregor, Institut Pasteur, Paris, FR and Princeton University, US
- Barbara Ann Halkier, University of Copenhagen, DK
- Birgitta Henriques Normark, Karolinska Institutet, Stockholm, SE
- Elina Ikonen, University of Helsinki, FI
- Sten Eirik W. Jacobsen, Karolinska Institutet, Stockholm, SE, and University of Oxford, UK
- Peter Jonas, Institute of Science and Technology Austria (IST), Klosterneuburg, AT
- Paul Lehner, University of Cambridge, UK
- Ruth E. Ley, MPI fuer Entwicklungsbiologie, Tuebingen, DE
- Purificacion Lopez-Garcia, CNRS, Universite Paris-Sud, Orsay, FR
- Susan E. Mango, University of Basel, CH
- Giovanni Marsicano, NeuroCentre Magendie, U1215 INSERM and University of Bordeaux, FR
- Adele L. Marston, Wellcome Centre for Cell Biology, Edinburgh, UK
- Roberto Mayor, University College London, UK
- Ron Milo, Weizmann Institute of Science, Rehovot, IL
- Garib Murshudov, MRC Laboratory of Molecular Biology, Cambridge, UK
- Marcin Nowotny, International Institute of Molecular and Cell Biology, Warsaw, PL
- Lalita Ramakrishnan, MRC LMB / University of Cambridge, UK
- Katrin Rittinger, Francis Crick Institute, London, UK
- Aurelien Roux, University of Geneva, CH
- Rickard Sandberg, Karolinska Institutet, Stockholm, SE
- James Sharpe, EMBL Barcelona, ES
- Bruno Silva-Santos, Instituto de Medicina Molecular Joao Lobo Antunes, Lisbon, PT
- Nicole Soranzo, Wellcome Sanger Institute and University of Cambridge, UK
- Robert Tampe, Biocenter, Goethe University, Frankfurt, DE
- Manuel Thery, CEA at Hopital St. Louis, Paris, FR
- Miguel Torres, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, ES
- James M. Turner, Francis Crick Institute, London, UK
- Stepanka Vanacova, Central European Institute of Technology (CEITEC), Masaryk University, Brno, CZ
- Eric Vivier, Centre d’Immunologie de Marseille Luminy, FR and Innate Pharma, Marseille, FR
- Julia Vorholt, ETH Zurich, CH
- Patrick Wincker, Genoscope, Evry, FR
- Claire Wyart, Institut du Cerveau et de la Moelle epiniere (ICM), Paris, FR
New EMBO Associate Members 2019
- Frederic J. de Sauvage, Genentech, South San Francisco, US
- Yoshihide Hayashizaki, RIKEN Preventive Medicine & Diagnosis Innovation Program, Saitama, JP
- Eva Nogales, HHMI, University of California and Lawrence Berkeley National Laboratory, Berkeley, US
- Noriko Osumi, Tohoku University, Sendai, JP
- Fernando J. Pitossi, Fundacion Instituto Leloir – CONICET, Buenos Aires, AR
- G.V. Shivashankar, National University of Singapore, SG
- Jennifer L. Stow, University of Queensland, Brisbane, AU
- Joanna Wysocka, Stanford University, US
###
About EMBO
EMBO is an organization of more than 1800 leading researchers that promotes excellence in the life sciences in Europe and beyond. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. For more information: http://www.
Media Contact
Tilmann Kiessling
[email protected]
https:/
